Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Duo Zeng"'
Publikováno v:
BMC Medical Education, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background History-taking is an essential clinical competency for qualified doctors. The limitations of the standardized patient (SP) in taking history can be addressed by the virtual standardized patient (VSP). This paper investigates the a
Externí odkaz:
https://doaj.org/article/eb4fdc7f9fc444ecba1d59e53205c87f
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 3, Pp 241-244 (2024)
With the continuous innovation of genomics, proteomics and molecular biological detection technology, the treatment of non-small cell lung cancer (NSCLC) has changed from traditional chemotherapy to immunotherapy and targeted therapy. Among them, mol
Externí odkaz:
https://doaj.org/article/6569d7d40a5f48e8b286bdd55a430cbf
Autor:
Xuhui Yuan, Cong Ma, Jiayu Li, Junhong Li, Ronghui Yu, Feng Cai, Gaoyang Qu, Bo Yu, Lang Liu, Duo Zeng, QuanHui Jiao, Qi Liao, Xiaobin Lv
Publikováno v:
Journal of Bone Oncology, Vol 39, Iss , Pp 100472- (2023)
Background: Osteosarcoma is most prevalently found primary malignant bone tumors, with primary metastatic patients accounting for approximately 25% of all osteosarcoma patients, yet their 5-year OS remains below 30%. Bilirubin plays a key role in oxi
Externí odkaz:
https://doaj.org/article/35b47a0499e74bbe98cc16d5a088d145
Autor:
Jiayu Li, Xuhui Yuan, Cong Ma, Junhong Li, Gaoyang Qu, Bo Yu, Feng Cai, Yuanxiang Peng, Lang Liu, Duo Zeng, QuanHui Jiao, Jiongfeng Zhang, Xiaohui Luo, Qi Liao, Xiao-Bin Lv
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveRecent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clari
Externí odkaz:
https://doaj.org/article/2122c12f949b4ed0a8d623a7cf55a1fe
Autor:
Bo Yu, Lang Liu, Feng Cai, Yuanxiang Peng, Xiaofeng Tang, Duo Zeng, Teng Li, Feifei Zhang, Yiping Liang, Xuhui Yuan, Jiayu Li, Zhengzai Dai, Qi Liao, Xiao-Bin Lv
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Osteosarcoma (OS) is a tumour with a high malignancy level and a poor prognosis. First-line chemotherapy for OS has not been improved for many decades. Bromodomain and extraterminal domain (BET) and histone deacetylases (HDACs) re
Externí odkaz:
https://doaj.org/article/50aa3c8b57144790a8c5152053c85c03
Autor:
Yuhong Guo, Bin Lv, Renfeng Liu, Zhengzai Dai, Feifei Zhang, Yiping Liang, Bo Yu, Duo Zeng, Xiao-Bin Lv, Zhiping Zhang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract The metabolic change of tumor cells is an extremely complicated process that involves the intersection and integration of various signal pathways. Compared with normal tissues, cancer cells show distinguished metabolic characteristics called
Externí odkaz:
https://doaj.org/article/cd8f9d98ab6a48edb8a53ded5c192d00
Autor:
Duo Zeng
Publikováno v:
Communications in Algebra. :1-15
Autor:
Duo Zeng, Jiayu Li, Xuhui Yuan, Feng Cai, Bo Yu, Lang Liu, Qinchan Chen, FeiFei Zhang, Yiping Liang, Xiaofeng Tang, Yuanxiang Peng, Gaoyang Qu, Pengyun Wu, QuanHui Jiao, Longhua Sun, Xiao-Bin Lv, Qi Liao
Publikováno v:
Aging. 15:2450-2459
Autor:
Xiao-Bin Lv, Duo Zeng, Feifei Zhang, Feng Cai, Xiaofeng Tang, Bo Yu, Xuhui Yuan, Jiayu Li, Liu Lang, Bin Lv, Yiping Liang, Yuanxiang Peng, Qi Liao, Yuhong Guo, Min Wang
Publikováno v:
Biochemical and Biophysical Research Communications. 554:25-32
Osteosarcoma, a highly aggressive malignant tumor of the bone, usually occurs in children and young adults. However, although the considerable achievement in the clinical treatment of osteosarcoma recent years, the overall survival of osteosarcoma pa
Autor:
Zhengzai Dai, Bo Yu, Xiao-Bin Lv, Renfeng Liu, Zhiping Zhang, Feifei Zhang, Yuhong Guo, Bin Lv, Duo Zeng, Yiping Liang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
Cancer Cell International
Cancer Cell International
The metabolic change of tumor cells is an extremely complicated process that involves the intersection and integration of various signal pathways. Compared with normal tissues, cancer cells show distinguished metabolic characteristics called metaboli